Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Finn, Warnke & Gayton is a specialized accounting and management consulting firm based in Wellesley Hills, Massachusetts, that primarily serves the life sciences and biotechnology sectors. Led by founding partner Joseph F. Finn, Jr., the firm is widely recognized for its expertise in managing distressed enterprises, bankruptcy accounting, and acting as an Assignee for the Benefit of Creditors (ABC). The firm frequently facilitates the liquidation and sale of intellectual property and assets for biotech companies that have ceased operations, including notable cases such as Epix Pharmaceuticals and Prospect Therapeutics. Their services provide a critical financial and legal bridge for the redistribution of life science technologies and assets within the industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Finn, Warnke & Gayton.